265 related articles for article (PubMed ID: 18644510)
1. Cardiovascular risk assessment and hyperlipidemia.
Becker J
Crit Care Nurs Clin North Am; 2008 Sep; 20(3):277-85. PubMed ID: 18644510
[TBL] [Abstract][Full Text] [Related]
2. Common obstacles in lipid management.
Elpers M
Crit Care Nurs Clin North Am; 2008 Sep; 20(3):287-95. PubMed ID: 18644511
[TBL] [Abstract][Full Text] [Related]
3. Hyperlipidemia treatment in children: the younger, the better.
Gauer R
Am Fam Physician; 2010 Sep; 82(5):460. PubMed ID: 20822078
[No Abstract] [Full Text] [Related]
4. Treatment of hyperlipidemia.
Henley E; Chang L; Hollander S
J Fam Pract; 2002 Apr; 51(4):370-6. PubMed ID: 11978263
[TBL] [Abstract][Full Text] [Related]
5. Preventing coronary heart disease and stroke with aggressive statin therapy in older adults using a team management model.
Mason CM
J Am Acad Nurse Pract; 2009 Jan; 21(1):47-53. PubMed ID: 19125895
[TBL] [Abstract][Full Text] [Related]
6. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.
Robson J
Heart; 2008 Oct; 94(10):1331-2. PubMed ID: 18701534
[No Abstract] [Full Text] [Related]
7. The 2003 Canadian recommendations for dyslipidemia management: revisions are needed.
Manuel DG; Tanuseputro P; Mustard CA; Schultz SE; Anderson GM; Ardal S; Alter DA; Laupacis A
CMAJ; 2005 Apr; 172(8):1027-31. PubMed ID: 15824409
[No Abstract] [Full Text] [Related]
8. New options in lipid management--can we extend the benefits of current therapy? Introduction.
Gotto AM; Paoletti R
Am Heart J; 2002 Dec; 144(6 Suppl):S19-20. PubMed ID: 12486411
[No Abstract] [Full Text] [Related]
9. Drug treatment of lipid disorders.
Knopp RH
N Engl J Med; 1999 Aug; 341(7):498-511. PubMed ID: 10441607
[No Abstract] [Full Text] [Related]
10. Lipid management in the geriatric patient.
Nair AP; Darrow B
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
Behrens GM
N Engl J Med; 2005 Apr; 352(16):1721-2; author reply 1721-2. PubMed ID: 15843678
[No Abstract] [Full Text] [Related]
12. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.
Kidney Disease Outcomes Quality Initiative (K/DOQI) Group
Am J Kidney Dis; 2003 Apr; 41(4 Suppl 3):I-IV, S1-91. PubMed ID: 12671933
[No Abstract] [Full Text] [Related]
13. Identifying women at risk for coronary artery disease.
Birchfield PC
AAOHN J; 2003 Jan; 51(1):15-22. PubMed ID: 12596341
[TBL] [Abstract][Full Text] [Related]
14. Lipid-lowering therapy--benefits and risks.
Abinader EG
Isr Med Assoc J; 2007 Feb; 9(2):132-3; author reply 133-4. PubMed ID: 17354321
[No Abstract] [Full Text] [Related]
15. [44. Normalizing blood lipids--with diet, sports and antilipemic agents].
Faust M; Krone W
MMW Fortschr Med; 2003 May; 145(19):I-X; quiz XI-XII. PubMed ID: 12813992
[No Abstract] [Full Text] [Related]
16. Was caution the best advice?
Parchman ML
J Fam Pract; 2007 Feb; 56(2):112-3; author reply 113. PubMed ID: 17611993
[No Abstract] [Full Text] [Related]
17. Lipid-lowering therapy--benefits and risks.
Shechter M
Isr Med Assoc J; 2007 Feb; 9(2):133; author reply 133-4. PubMed ID: 17348492
[No Abstract] [Full Text] [Related]
18. Lipids and lipoproteins in women.
Sattler AM; Soufi M; Maisch B; Schaefer JR
Herz; 2005 Aug; 30(5):368-74; quiz 429-30. PubMed ID: 16132239
[TBL] [Abstract][Full Text] [Related]
19. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.
; ; ; ; ;
Heart; 2005 Dec; 91 Suppl 5(Suppl 5):v1-52. PubMed ID: 16365341
[No Abstract] [Full Text] [Related]
20. [Statines for all or individualized lipid lowering therapy?].
Parhofer K
MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
[No Abstract] [Full Text] [Related]
[Next] [New Search]
